Laura Pyle Selected Research

Laura Pyle Research Topics

Disease

55	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 12/2022 - 09/2010
30	Insulin Resistance 01/2022 - 08/2012
16	Obesity 07/2022 - 03/2016
15	Type 2 Diabetes Mellitus (MODY) 05/2021 - 03/2010
7	Hyperinsulinism (Hyperinsulinemia) 09/2020 - 05/2015
6	Hypoglycemia (Reactive Hypoglycemia) 01/2022 - 03/2010
6	Prediabetic State (Prediabetes) 01/2022 - 03/2015
6	Diabetic Nephropathies (Diabetic Nephropathy) 01/2021 - 01/2014
5	Cardiovascular Diseases (Cardiovascular Disease) 10/2022 - 06/2015
5	Cystic Fibrosis (Mucoviscidosis) 01/2022 - 01/2018
5	Infections 11/2020 - 09/2017
4	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 07/2022 - 01/2019
4	Albuminuria 05/2022 - 10/2014
4	Inflammation (Inflammations) 01/2021 - 05/2015
4	Chronic Renal Insufficiency 01/2018 - 10/2015
3	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 01/2017
3	Overweight 01/2022 - 01/2017
2	Liver Diseases (Liver Disease) 10/2022 - 01/2022
2	Hyperglycemia 01/2022 - 01/2014
2	Hypertension (High Blood Pressure) 01/2021 - 10/2016
2	Graft vs Host Disease (Graft-Versus-Host Disease) 10/2020 - 12/2019
2	Metabolic Diseases (Metabolic Disease) 01/2020 - 06/2018
2	Hypertriglyceridemia 01/2019 - 11/2014
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2017 - 09/2010
2	Diabetic Retinopathy (Retinopathy, Diabetic) 05/2016 - 10/2014
1	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 01/2022
1	Klinefelter Syndrome (Klinefelter's Syndrome) 01/2022
1	Dyslipidemias (Dyslipidemia) 01/2022
1	Primary hyperoxaluria type 1 11/2021
1	Ketosis 11/2021
1	Birth Weight (Birth Weights) 11/2021
1	Autoimmune Diseases (Autoimmune Disease) 01/2021
1	Hypoxia (Hypoxemia) 12/2020
1	Chronic Hepatitis C 01/2020

Drug/Important Bio-Agent (IBA)

40	Glucose (Dextrose)FDA LinkGeneric 12/2022 - 08/2012
27	Insulin (Novolin)FDA Link 01/2022 - 09/2010
12	AlbuminsIBA 05/2022 - 11/2014
10	Metformin (Glucophage)FDA LinkGeneric 07/2022 - 06/2012
10	Hemoglobins (Hemoglobin)IBA 01/2021 - 08/2012
9	AutoantibodiesIBA 01/2022 - 09/2010
8	CreatinineIBA 05/2022 - 11/2014
8	LipidsIBA 12/2019 - 09/2010
7	Nonesterified Fatty Acids (NEFA)IBA 12/2019 - 05/2015
6	Testosterone (Sustanon)FDA Link 07/2022 - 10/2019
6	Blood Glucose (Blood Sugar)IBA 01/2022 - 01/2014
6	C-PeptideIBA 01/2022 - 09/2010
5	Biomarkers (Surrogate Marker)IBA 12/2022 - 01/2018
5	LeptinIBA 01/2021 - 03/2016
5	oxidized low density lipoproteinIBA 01/2016 - 10/2014
4	Amino Acids FDA Link 05/2022 - 01/2019
4	HDL CholesterolIBA 07/2021 - 11/2014
4	Triglycerides (Triacylglycerol)IBA 04/2021 - 11/2014
4	AdiponectinIBA 01/2021 - 03/2016
4	AndrogensIBA 10/2019 - 05/2015
3	C-Reactive ProteinIBA 01/2021 - 01/2018
3	CalciumIBA 12/2019 - 10/2014
3	Uric Acid (Urate)IBA 01/2018 - 10/2014
3	LDL CholesterolIBA 10/2015 - 11/2014
3	ApolipoproteinsIBA 10/2015 - 11/2014
2	p-Aminohippuric Acid (p-Aminohippurate)FDA Link 05/2022 - 12/2020
2	Iohexol (Omnipaque)FDA Link 05/2022 - 12/2020
2	Hormones (Hormone)IBA 01/2022 - 10/2019
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 12/2021 - 06/2012
2	HDL LipoproteinsIBA 07/2021 - 01/2017
2	Sex Hormone-Binding GlobulinIBA 04/2021 - 10/2019
2	AntigensIBA 01/2019 - 01/2018
2	UromodulinIBA 01/2019 - 01/2019
2	1,5-anhydroglucitolIBA 11/2017 - 05/2016
2	FructosamineIBA 11/2017 - 05/2016
2	Anti-Bacterial Agents (Antibiotics)IBA 03/2017 - 06/2016
2	Apolipoproteins B (ApoB)IBA 10/2015 - 06/2015
1	EnzymesIBA 10/2022
1	Tricarboxylic AcidsIBA 05/2022
1	Carboxylic AcidsIBA 05/2022
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022
1	Antipsychotic Agents (Antipsychotics)IBA 01/2022
1	Combined Oral ContraceptivesIBA 01/2022
1	Indicators and Reagents (Reagents)IBA 12/2021
1	lumasiranIBA 11/2021
1	KetonesIBA 11/2021
1	preproinsulinIBA 10/2021
1	AutoantigensIBA 10/2021
1	ProteomeIBA 07/2021
1	etonogestrel (Implanon)FDA Link 02/2021
1	Contraceptive Agents (Contraceptives)IBA 02/2021
1	Alanine Transaminase (SGPT)IBA 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	ProinsulinIBA 01/2021
1	Oxygen (Dioxygen)IBA 12/2020
1	Antiviral Agents (Antivirals)IBA 01/2020
1	HLA-DQB1 antigen (HLA DQB1)IBA 01/2020
1	SteroidsIBA 12/2019

Therapy/Procedure

12	Glycemic Control 12/2022 - 03/2010
10	Therapeutics 08/2020 - 05/2014
4	Length of Stay 10/2020 - 02/2017
2	Lasers (Laser) 05/2016 - 10/2014
1	Artificial Pancreas 01/2022
1	RNAi Therapeutics 11/2021
1	Critical Care (Surgical Intensive Care) 11/2020
1	Hematopoietic Stem Cell Transplantation 10/2020